AzTrials
AzTrials

Uncomplicated Severe Acute MalnutritionSAMPOORNANCT01705769

Effects of Three Feeding Regimens on Recovery of Uncomplicated Severely Acute Malnourished Children

A study testing Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods in people with Uncomplicated Severe Acute Malnutrition, run by Society for Applied Studies at 3 sites in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project aims to assess the efficacy of three options under consideration in India for home management of Severe Acute Malnutrition (SAM). The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or… Read more about this study

Who is it for?
Ages 6 to 59 months
Conditions the study is for
Uncomplicated Severe Acute Malnutrition
What is being tested?
Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods
Could I receive a placebo?
No, everyone receives an active treatment
How many people
911 participants
Where
3 sitesIndia
Study dates
Oct 2012to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 59 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 6 to 59 months
  • SAM, defined as Weight for height less than -3 SD of WHO standard or oedema of both feet or both.

Who cannot join

  • Complicated SAM defined as child with SAM having signs of severe illness requiring hospitalization
  • Known allergy to animal milk or peanuts
  • Likely to leave the study area permanently in the next 16 weeks

Trial locations and contacts

3 sites in 1 country.

India3 sites
  • Centre for Health Research and Development, Society for Applied Studies

    New Delhi, National Capital Territory of Delhi, 110062

  • Action Research & Training for Health (ARTH)

    Udaipur, Rajasthan, 313004

  • Christian Medical College

    Vellore, Tamil Nadu, 632002

Other trials in India

About this study

Official title: To Evaluate the Impact of Three Feeding Regimens on the Recovery of Children From Uncomplicated Severe Acute Malnutrition (SAM) in India and to Use the Evidence to Inform National Policy

This project aims to assess the efficacy of three options under consideration in India for home management of Severe Acute Malnutrition (SAM). The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with comparison group.

Read the detailed description

India accounts for over half the global burden of severe acute malnutrition (SAM) in the world. While it is important to accelerate efforts to prevent SAM, effective management of children suffering from it is critical for reducing child mortality and achieving MDG1 and MDG4.

Available evidence mostly from studies in Africa suggest that home based management of uncomplicated SAM with Ready to Use Therapeutic Foods (RUTF) is at least as efficacious as facility-based management and that locally produced RUTF is as efficacious as centrally produced RUTF. More evidence on efficacy and effectiveness of home based management using RUTF is needed to decide if this intervention offers substantial advantages over home-prepared foods in the Indian settings. Additionally, there is a demand to generate evidence of efficacy of locally produced RUTF as compared to that of centrally produced RUTF. These issues can only be resolved through a well designed randomized controlled trial.

This project therefore aims to assess the efficacy of three options under consideration in India for home management of SAM. The investigators propose to conduct a multi-center randomized controlled trial to determine the efficacy of two community-supported home-based regimes using centrally or locally produced Ready to Use Therapeutic Foods (RUTF) for recovery from uncomplicated SAM after 16 weeks of management, compared with an augmented home-prepared foods regimen. The trial will enroll 911 children with uncomplicated SAM and will have enough statistical power to detect a 15% or greater difference in recovery rates between either one of the intervention groups compared with the comparison group.

Participants: The study will be conducted in three sites - urban slums and resettlement colonies in the national capital region, rural (predominantly tribal) Rajasthan, rural and urban Tamil Nadu. Field workers will survey the study area to measure mid-upper arm circumference (MUAC) in children 6 to 59 months of age and refer children with MUAC less than 13 cm to a study clinic. At the study clinic, anthropometric measurements will be taken and children with weight for height less than -3 SD of the WHO standards or oedema of both feet will be offered participation in the study.

Intervention and Comparison Regimes for Home Management of SAM

  • Children randomized to the first intervention arm (Arm 1) will receive a centrally produced RUTF.
  • Children randomized to the second intervention arm (Arm 2) will receive a locally produced RUTF.
  • Children randomized to the comparison group (Arm 3) will receive augmented Home-Prepared Foods.

The amount of food advised for each child in all the 3 study arms are calculated to provide 175cal/kg body weight per day. These foods will be given to children from the time of enrollment until recovery (but not beyond 16 weeks). Caregivers of all enrolled children will receive counseling on frequency of feeding, amounts to be fed, encouraging children to continue breastfeeding and good hygiene practices. Additional support through a volunteer from the community will be provided to mothers who give consent, to assist in feeding the child.

Management Phases: The management will be in two phases:

Treatment Phase: From enrolment until recovery or 16 weeks (whichever is earlier), enrolled children will be provided the foods according to the study group they are randomized to, and counselled on their use.

Sustenance Phase: After completion of the treatment phase, children in all arms will be referred to the closest Anganwadi centre from where he/she will access supplementary foods given to children as a part of the ICDS strategy. The sustenance phase will last for 16 weeks after end of treatment phase.

Outcomes: A trained and standardized team of field workers will conduct weekly anthropometric measurements and also record morbidity, hospitalizations and deaths from enrolment, weekly till recovery or 16 weeks whichever is earlier. In addition, mortality and hospitalization data will be collected at 16 weeks post treatment phase.

The primary outcome will be recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema).

Secondary outcomes will include:

  • To compare the weight gain (in grams/kg body weight/day) from enrolment till recovery, or till 16 weeks in those who do not attain recovery, at 16 weeks after recovery.
  • To compare the time required to reach recovery (in weeks).
  • To determine the incidence and prevalence of diarrhea, ARI and fever during the treatment phase
  • To compare the mortality and hospitalizations during the treatment phase, 16 weeks after recovery
  • To compare the perceptions of families, health care providers and ICDS functionaries regarding feasibility of use of the feeding regimens in a sub sample from enrolment tom completion of treatment phase
  • To ascertain factors which affect recovery, at 16 weeks post enrolment in those who do not recover.
  • To compare the perceptions of families regarding Anganwadi centre experience at the end of sustenance phase.
  • To compare the proportion of children with weight for height greater than or equal to -2 SD and absence of oedema feet at 16 weeks after recovery (or 32 weeks after enrolment for those who do not recover)
  • To document the costs of implementing the feeding regimens till end of treatment phase.

This will include:

  1. Estimation of costs of human resource and other inputs
  2. Estimation of household costs
  3. Costs per week per child estimated based on total costs and covered population

The project has been approved by the National Research Alliance for SAM constituted by the Department of Health and Family Welfare, Department of Health Research and Department of Biotechnology. It will be coordinated by Centre for Health Research and Development-Society for Applied Studies. WHO will provide technical support and monitoring for the study implementation as a response to a request from the Alliance. Oversight to the study will be provided by a Technical Advisory group constituted by the Alliance and a Data Safety Monitoring Board. Clearances have been sought from the state governments of Delhi, Rajasthan and Tamil Nadu.

Being tested
Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced, High energy and micronutrient rich foods
Keywords
treatment, severe acute malnutrition
Medical subject headings
Severe Acute Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ready to Use Therapeutic Food-Centrally producedOther

    Ready to Use Therapeutic Food-Centrally produced by an Indian company.

  • Ready to Use Therapeutic Food-Locally producedOther

    Ready to Use Therapeutic Food prepared by the study team

  • High energy and micronutrient rich foodsOther

    High energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them

Study groups in NCT01705769
Study groupRoleWhat they receive
RUTF-Centrally producedExperimentalReady to Use Therapeutic Food-Centrally produced by an Indian company
Receives: Other: Ready to Use Therapeutic Food-Centrally produced
RUTF-Locally producedExperimentalReady to Use Therapeutic Food-Locally produced by the study team at each study site
Receives: Other: Ready to Use Therapeutic Food-Locally produced
High energy and micronutrient rich foodsActive comparatorHigh energy and micronutrient rich foods prepared by caregivers at home using ingredients provided to them
Receives: Other: High energy and micronutrient rich foods

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema of both feet)

    Measured: Weekly till recovery or 16 weeks after enrollment, whichever is earlier

Secondary outcomes (9)
  1. Mortality and hospitalizations

    Measured: Weekly till 16 weeks or recovery and at end of sustenance phase

  2. Rate of weight gain (grams/kg body wt/day)

    Measured: From enrollment till recovery or 16 weeks whichever is earlier

  3. Time required to reach recovery

    Measured: From enrollment till recovery or 16 weeks whichever is earlier

  4. Íncidence and prevalence of diarrhea, ARI and fever during treatment phase

    Measured: From enrollment till recovery or 16 weeks whichever is earlier

  5. Proportion of children with weight for height greater than or equal to -2 SD and absence of oedema of feet

    Measured: At the end of sustenance phase

  6. Cost of three feeding regimens

    Measured: Enrollment to end of treatment phase

  7. Feedback from families, health care providers and ICDS functionaries about the feeding regimens regarding perceptions and feasibility of use

    Measured: Enrollment to end study

  8. Factors which affect recovery

    Measured: At 16 weeks post enrolment in those that have not recovered

  9. Perception of families regarding anganwadi centre experiences at the end of sustenance phase

    Measured: from end of treatment phase to end of sustanence phase

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2012 (estimated)
  2. Study startOct 2012
  3. Primary completionApr 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
911 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01705769
Sponsor's protocol ID
RPC538
Other IDs
CTRI/2012/10/003054
Acronym
SAMPOORNA
Status last verified
Jun 2015
First submitted
8 Oct 2012
Last updated
8 Jun 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Garg CC, Mazumder S, Taneja S, Shekhar M, Mohan SB, Bose A, Iyengar SD, Bahl R, Martines J, Bhandari N. Costing of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Glob Health. 2018 Mar 6;3(2):e000702. doi: 10.1136/bmjgh-2017-000702. eCollection 2018.

    PubMed 29527358
  • Bhandari N, Mohan SB, Bose A, Iyengar SD, Taneja S, Mazumder S, Pricilla RA, Iyengar K, Sachdev HS, Mohan VR, Suhalka V, Yoshida S, Martines J, Bahl R. Efficacy of three feeding regimens for home-based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Glob Health. 2016 Dec 30;1(4):e000144. doi: 10.1136/bmjgh-2016-000144. eCollection 2016.

    PubMed 28588982

Questions about this trial

What is this clinical trial studying?

A study testing Ready to Use Therapeutic Food-Centrally produced, Ready to Use Therapeutic Food-Locally produced and High energy and micronutrient rich foods in people with Uncomplicated Severe Acute Malnutrition, run by Society for Applied Studies at 3 sites in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recovery by 16 weeks after enrollment (defined as achieving weight for height greater than or equal to -2 SD and absence of oedema of both feet) (time frame: Weekly till recovery or 16 weeks after enrollment, whichever is earlier). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01705769, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in